Global PCC Therapy Market Research Report 2026(Status and Outlook)

February 2026 | 130 pages | ID: G9D993513057EN
Bosson Research

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
PCC Therapy (Prothrombin Complex Concentrate therapy) is a treatment approach based on highly purified, formulated vitamin K?dependent coagulation factors designed to rapidly restore hemostasis and reverse deficiency caused by vitamin K antagonists (e.g., warfarin). PCC products typically contain Factors II, VII, IX, and X; some formulations include Proteins C/S or activated components and are indicated in emergency bleeding, perioperative anticoagulation reversal, and trauma care. Compared with fresh frozen plasma, PCCs offer low infusion volume, rapid onset, and improved viral safety, becoming essential agents in critical care and surgical rescue. Advances in fractionation, quality control, and regulatory frameworks have driven innovation in indications, ease of administration, and formulation variety, enabling broader adoption across emergency systems and national stockpiles.The PCC therapy market benefits from intrinsic and sustained clinical demand across emergency, surgical, and critical care settings where rapid, controllable hemostasis and anticoagulation reversal are required. Leading manufacturers? annual reports and investor presentations highlight the incorporation of PCCs into clinical guidelines and care pathways, accelerating hospital procurement and centralized bidding priority. Regional industrial policies and national medical stockpiling initiatives create policy tailwinds for local production and channel expansion, enabling products to penetrate beyond tertiary centers into broader healthcare networks. On the technology side, formulation improvements, optimized preparations, and strengthened cold-chain logistics increase PCC accessibility for emergency and pre-hospital care, collectively amplifying market growth drivers. Growth faces tangible constraints: upstream plasma supply is subject to donor-collection policies and geographic concentration, directly constraining capacity and influencing cost structures. Regulatory expectations for plasma-derived products?covering safety, traceability, and viral inactivation?raise compliance and quality-investment burdens. Commercially, alternative approaches (specific reversal agents, recombinant factors) and reimbursement or centralized procurement pressures may compress margins and force competition on scale and differentiation. Additionally, the loss of significant contracts or shifts in procurement patterns can produce short-term sales volatility, requiring agile commercial and manufacturing responses. Clinical use is evolving from single-indication deployment toward multi-scenario, multidisciplinary integration: beyond anticoagulant reversal, PCC applications in trauma, transplant perioperative management, and obstetric hemorrhage are expanding, prompting hospitals to create cross-departmental usage protocols. With updates to clinical guidelines and reimbursement lists, pharmacy and critical care teams are increasingly positioning PCCs as standard elements of emergency toolkits, improving accessibility and stockpiling. Demand is shifting from purely episodic ?rescue? use to a dual model of routine readiness plus emergency reserves, motivating manufacturers to invest in logistics, clinician training, and clinical-support services to secure long-term procurement and prescribing loyalty. High-quality, traceable human plasma remains the central raw material for PCC manufacture; the reach of plasma collection networks and the robustness of viral-inactivation processes determine supply security and cost base. Critical upstream inputs also include chromatography resins, filtration membranes, and GMP consumables?their localization and supply stability materially affect manufacturing flexibility. To hedge material risk, the sector is investing in hybrid processes and recombinant alternatives, offering technical routes for long-term sustainability and potential differentiation for new entrants. Overall, modernization, automation, and localization of the upstream supply chain will be pivotal to improving resilience and lowering total production costs.

The global PCC Therapy market size was estimated at USD 1324.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.40% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global PCC Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global PCC Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the PCC Therapy market.

Global PCC Therapy Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Biotest
Hualan Biological

Market Segmentation (by Type)

Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other

Market Segmentation (by Application)

Hemophilia B
Acquired Coagulation Factor Deficiency

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PCC Therapy Market
Overview of the regional outlook of the PCC Therapy Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PCC Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of PCC Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of PCC Therapy
1.2 Key Market Segments
  1.2.1 PCC Therapy Segment by Type
  1.2.2 PCC Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PCC THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global PCC Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global PCC Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PCC THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global PCC Therapy Product Life Cycle
3.3 Global PCC Therapy Sales by Manufacturers (2020-2025)
3.4 Global PCC Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 PCC Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global PCC Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 PCC Therapy Market Competitive Situation and Trends
  3.8.1 PCC Therapy Market Concentration Rate
  3.8.2 Global 5 and 10 Largest PCC Therapy Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PCC THERAPY INDUSTRY CHAIN ANALYSIS

4.1 PCC Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PCC THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global PCC Therapy Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to PCC Therapy Market
5.7 ESG Ratings of Leading Companies

6 PCC THERAPY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PCC Therapy Sales Market Share by Type (2020-2025)
6.3 Global PCC Therapy Market Size by Type (2020-2025)
6.4 Global PCC Therapy Price by Type (2020-2025)

7 PCC THERAPY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PCC Therapy Market Sales by Application (2020-2025)
7.3 Global PCC Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global PCC Therapy Sales Growth Rate by Application (2020-2025)

8 PCC THERAPY MARKET SALES BY REGION

8.1 Global PCC Therapy Sales by Region
  8.1.1 Global PCC Therapy Sales by Region
  8.1.2 Global PCC Therapy Sales Market Share by Region
8.2 Global PCC Therapy Market Size by Region
  8.2.1 Global PCC Therapy Market Size by Region
  8.2.2 Global PCC Therapy Market Size by Region
8.3 North America
  8.3.1 North America PCC Therapy Sales by Country
  8.3.2 North America PCC Therapy Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe PCC Therapy Sales by Country
  8.4.2 Europe PCC Therapy Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific PCC Therapy Sales by Region
  8.5.2 Asia Pacific PCC Therapy Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America PCC Therapy Sales by Country
  8.6.2 South America PCC Therapy Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa PCC Therapy Sales by Region
  8.7.2 Middle East and Africa PCC Therapy Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PCC THERAPY MARKET PRODUCTION BY REGION

9.1 Global Production of PCC Therapy by Region(2020-2025)
9.2 Global PCC Therapy Revenue Market Share by Region (2020-2025)
9.3 Global PCC Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America PCC Therapy Production
  9.4.1 North America PCC Therapy Production Growth Rate (2020-2025)
  9.4.2 North America PCC Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe PCC Therapy Production
  9.5.1 Europe PCC Therapy Production Growth Rate (2020-2025)
  9.5.2 Europe PCC Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan PCC Therapy Production (2020-2025)
  9.6.1 Japan PCC Therapy Production Growth Rate (2020-2025)
  9.6.2 Japan PCC Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China PCC Therapy Production (2020-2025)
  9.7.1 China PCC Therapy Production Growth Rate (2020-2025)
  9.7.2 China PCC Therapy Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 CSL Behring
  10.1.1 CSL Behring Basic Information
  10.1.2 CSL Behring PCC Therapy Product Overview
  10.1.3 CSL Behring PCC Therapy Product Market Performance
  10.1.4 CSL Behring Business Overview
  10.1.5 CSL Behring SWOT Analysis
  10.1.6 CSL Behring Recent Developments
10.2 Grifols
  10.2.1 Grifols Basic Information
  10.2.2 Grifols PCC Therapy Product Overview
  10.2.3 Grifols PCC Therapy Product Market Performance
  10.2.4 Grifols Business Overview
  10.2.5 Grifols SWOT Analysis
  10.2.6 Grifols Recent Developments
10.3 Octapharma
  10.3.1 Octapharma Basic Information
  10.3.2 Octapharma PCC Therapy Product Overview
  10.3.3 Octapharma PCC Therapy Product Market Performance
  10.3.4 Octapharma Business Overview
  10.3.5 Octapharma SWOT Analysis
  10.3.6 Octapharma Recent Developments
10.4 Prothya Biosolutions
  10.4.1 Prothya Biosolutions Basic Information
  10.4.2 Prothya Biosolutions PCC Therapy Product Overview
  10.4.3 Prothya Biosolutions PCC Therapy Product Market Performance
  10.4.4 Prothya Biosolutions Business Overview
  10.4.5 Prothya Biosolutions Recent Developments
10.5 Takeda
  10.5.1 Takeda Basic Information
  10.5.2 Takeda PCC Therapy Product Overview
  10.5.3 Takeda PCC Therapy Product Market Performance
  10.5.4 Takeda Business Overview
  10.5.5 Takeda Recent Developments
10.6 Biotest
  10.6.1 Biotest Basic Information
  10.6.2 Biotest PCC Therapy Product Overview
  10.6.3 Biotest PCC Therapy Product Market Performance
  10.6.4 Biotest Business Overview
  10.6.5 Biotest Recent Developments
10.7 Hualan Biological
  10.7.1 Hualan Biological Basic Information
  10.7.2 Hualan Biological PCC Therapy Product Overview
  10.7.3 Hualan Biological PCC Therapy Product Market Performance
  10.7.4 Hualan Biological Business Overview
  10.7.5 Hualan Biological Recent Developments

11 PCC THERAPY MARKET FORECAST BY REGION

11.1 Global PCC Therapy Market Size Forecast
11.2 Global PCC Therapy Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe PCC Therapy Market Size Forecast by Country
  11.2.3 Asia Pacific PCC Therapy Market Size Forecast by Region
  11.2.4 South America PCC Therapy Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of PCC Therapy by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global PCC Therapy Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of PCC Therapy by Type (2026-2035)
  12.1.2 Global PCC Therapy Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of PCC Therapy by Type (2026-2035)
12.2 Global PCC Therapy Market Forecast by Application (2026-2035)
  12.2.1 Global PCC Therapy Sales (K MT) Forecast by Application
  12.2.2 Global PCC Therapy Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global PCC Therapy Market Size by Type (M USD)
Table 4. Global PCC Therapy Market Size by Application
Table 5. PCC Therapy Market Size Comparison by Region (M USD)
Table 6. Global PCC Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global PCC Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global PCC Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global PCC Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCC Therapy as of 2025)
Table 11. Global Market PCC Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global PCC Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PCC Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global PCC Therapy Sales by Type (K MT)
Table 27. Global PCC Therapy Market Size by Type (M USD)
Table 28. Global PCC Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global PCC Therapy Sales Market Share by Type (2020-2025)
Table 30. Global PCC Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global PCC Therapy Market Share by Type (2020-2025)
Table 32. Global PCC Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global PCC Therapy Sales (K MT) by Application
Table 34. Global PCC Therapy Market Size by Application
Table 35. Global PCC Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global PCC Therapy Sales Market Share by Application (2020-2025)
Table 37. Global PCC Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global PCC Therapy Market Share by Application (2020-2025)
Table 39. Global PCC Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global PCC Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global PCC Therapy Sales Market Share by Region (2020-2025)
Table 42. Global PCC Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global PCC Therapy Market Size by Region (2020-2025)
Table 44. North America PCC Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America PCC Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe PCC Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe PCC Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific PCC Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific PCC Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America PCC Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America PCC Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa PCC Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa PCC Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global PCC Therapy Production (K MT) by Region(2020-2025)
Table 55. Global PCC Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global PCC Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global PCC Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America PCC Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe PCC Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan PCC Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China PCC Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CSL Behring Basic Information
Table 63. CSL Behring PCC Therapy Product Overview
Table 64. CSL Behring PCC Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CSL Behring Business Overview
Table 66. CSL Behring SWOT Analysis
Table 67. CSL Behring Recent Developments
Table 68. Grifols Basic Information
Table 69. Grifols PCC Therapy Product Overview
Table 70. Grifols PCC Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Grifols Business Overview
Table 72. Grifols SWOT Analysis
Table 73. Grifols Recent Developments
Table 74. Octapharma Basic Information
Table 75. Octapharma PCC Therapy Product Overview
Table 76. Octapharma PCC Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Octapharma Business Overview
Table 78. Octapharma SWOT Analysis
Table 79. Octapharma Recent Developments
Table 80. Prothya Biosolutions Basic Information
Table 81. Prothya Biosolutions PCC Therapy Product Overview
Table 82. Prothya Biosolutions PCC Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Prothya Biosolutions Business Overview
Table 84. Prothya Biosolutions Recent Developments
Table 85. Takeda Basic Information
Table 86. Takeda PCC Therapy Product Overview
Table 87. Takeda PCC Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Takeda Business Overview
Table 89. Takeda Recent Developments
Table 90. Biotest Basic Information
Table 91. Biotest PCC Therapy Product Overview
Table 92. Biotest PCC Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Biotest Business Overview
Table 94. Biotest Recent Developments
Table 95. Hualan Biological Basic Information
Table 96. Hualan Biological PCC Therapy Product Overview
Table 97. Hualan Biological PCC Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Hualan Biological Business Overview
Table 99. Hualan Biological Recent Developments
Table 100. Global PCC Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 101. Global PCC Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America PCC Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 103. North America PCC Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe PCC Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 105. Europe PCC Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific PCC Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 107. Asia Pacific PCC Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America PCC Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 109. South America PCC Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa PCC Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa PCC Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global PCC Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 113. Global PCC Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global PCC Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 115. Global PCC Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 116. Global PCC Therapy Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of PCC Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PCC Therapy Market Size (M USD), 2025-2035
Figure 5. Global PCC Therapy Market Size (M USD) (2020-2035)
Figure 6. Global PCC Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PCC Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global PCC Therapy Product Life Cycle
Figure 13. PCC Therapy Sales Share by Manufacturers in 2025
Figure 14. Global PCC Therapy Revenue Share by Manufacturers in 2025
Figure 15. PCC Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market PCC Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by PCC Therapy Revenue in 2025
Figure 18. Industry Chain Map of PCC Therapy
Figure 19. Global PCC Therapy Market PEST Analysis
Figure 20. Global PCC Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global PCC Therapy Market Share by Type
Figure 27. Sales Market Share of PCC Therapy by Type (2020-2025)
Figure 28. Sales Market Share of PCC Therapy by Type in 2025
Figure 29. Market Share of PCC Therapy by Type (2020-2025)
Figure 30. Market Share of PCC Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global PCC Therapy Market Share by Application
Figure 33. Global PCC Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global PCC Therapy Sales Market Share by Application in 2025
Figure 35. Global PCC Therapy Market Share by Application (2020-2025)
Figure 36. Global PCC Therapy Market Share by Application in 2025
Figure 37. Global PCC Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global PCC Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global PCC Therapy Market Size by Region (2020-2025)
Figure 40. North America PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America PCC Therapy Sales Market Share by Country in 2024
Figure 43. North America PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America PCC Therapy Market Size by Country in 2024
Figure 45. U.S. PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada PCC Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada PCC Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico PCC Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico PCC Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe PCC Therapy Sales Market Share by Country in 2024
Figure 53. Europe PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe PCC Therapy Market Size by Country in 2024
Figure 55. Germany PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific PCC Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific PCC Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific PCC Therapy Market Size by Region in 2024
Figure 68. China PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America PCC Therapy Sales and Growth Rate (K MT)
Figure 79. South America PCC Therapy Sales Market Share by Country in 2024
Figure 80. South America PCC Therapy Market Size and Growth Rate (M USD)
Figure 81. South America PCC Therapy Market Size by Country in 2024
Figure 82. Brazil PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa PCC Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa PCC Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa PCC Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa PCC Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa PCC Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa PCC Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global PCC Therapy Production Market Share by Region (2020-2025)
Figure 103. North America PCC Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe PCC Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan PCC Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China PCC Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global PCC Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global PCC Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global PCC Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global PCC Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global PCC Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global PCC Therapy Market Share Forecast by Application (2026-2035)


More Publications